Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone for cough in patients with malignant disease
jRCT1021210068Not yet recruiting
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of hydromorphone in cancer and cough. Primary endpoint: Effectiveness of hydromorphone for cough. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
cancercough
Beyond the preview
Go deeper on jRCT1021210068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1021210068.